Lobia Dal (Cowpea)

About

What it is and where it shows up.

Lobia dal (cowpea, Vigna unguiculata) is a drought-tolerant legume widely cultivated across Asia, Africa, and the Americas, valued as a whole food staple and split pulse. It is consumed for its exceptionally high protein content (23–25%), complex carbohydrates (50–67%), dietary fibre, and water-soluble vitamins, and is used in curries, soups, salads, and flour-based products.

Safety summary

The regulatory and scientific consensus.

Lobia dal is broadly safe for the general adult population with no toxicological hazard established at normal dietary intakes; no ADI has been set by any major regulatory body. Like all legumes, it contains antinutritional factors (phytates, lectins, trypsin inhibitors) that are substantially reduced by soaking and cooking. Individuals with irritable bowel syndrome or inflammatory bowel disease may experience gas and bloating due to fermentable oligosaccharides.

Regulatory landscape

What food-safety regulators have decided.

Jurisdiction	Status	Note
FSANZ (Food Standards Australia New Zealand) (Australia)	Approved	Cowpea is recognised as a conventional legume food under the Australia New Zealand Food Standards Code. No ADI or maximum intake limit is prescribed.source
EFSA (European Food Safety Authority) (European Union)	Approved	Cowpea is a traditional whole food legume with no novel food status in the EU. No specific EFSA opinion restricting its use has been issued; it falls under general food law (Regulation EC 178/2002) as a safe conventional food.source
FSSAI (Food Safety and Standards Authority of India) (India)	Approved	Cowpea (lobia) is listed as a recognised pulse/legume under the Food Safety and Standards (Food Products Standards and Food Additives) Regulations, 2011. No maximum intake limit is prescribed; it is treated as a whole food commodity.source
FDA (Food and Drug Administration) (United States)	Approved	Cowpea and cowpea-derived ingredients (e.g. pea protein) are recognised as GRAS (Generally Recognised As Safe) under FDA regulations. Whole cowpea is an unregulated whole food commodity with no established ADI.source

Who should approach with care

Whose guidance would steer them away.

Ibs — Cowpea is rich in fermentable oligosaccharides (FODMAPs) such as galacto-oligosaccharides that can trigger bloating, gas, and abdominal discomfort in individuals with irritable bowel syndrome.

Ibd — High dietary fibre and residual lectins in insufficiently cooked cowpea may exacerbate gastrointestinal symptoms during active flares of inflammatory bowel disease.

Kidney Disease — Cowpea has a moderate potassium and phosphorus content; individuals with chronic kidney disease on potassium- or phosphorus-restricted diets should moderate intake and consult their dietitian.

Gout — Although evidence shows purine-rich plant-based legumes such as cowpea have little to no effect on gout attack risk compared to animal purines, individuals with active gout or hyperuricemia on strict low-purine diets may be advised to moderate portion sizes.

Infants — Whole or incompletely cooked legumes are not appropriate for infants under 12 months due to choking risk and the presence of antinutritional factors (lectins, phytates) that can impair mineral absorption in developing digestive systems.

Research citations

The sources behind this verdict.

1FDA. GRAS Notice GRN No. 581 – Pea Protein (cowpea/legume family). fda.gov
2PubMed. Cowpea (Vigna unguiculata L.) production, genetic resources and strategic breeding priorities for sustainable food security: a review, 2025. pmc.ncbi.nlm.nih.gov
3PubMed. Uric Acid and Plant-Based Nutrition, 2019. pmc.ncbi.nlm.nih.gov
4PubMed. Sprouting characteristics and associated changes in nutritional composition of cowpea (Vigna unguiculata), 2015. pmc.ncbi.nlm.nih.gov
5PubMed. Nutritional improvement of Lobia (Phaseolus vulgaris) by supplementation with poultry, mutton and beef meat, 2001. pubmed.ncbi.nlm.nih.gov

Independently researched5 citations